首页> 外文期刊>American Family Physician >Floppy Iris Syndrome: Why BPH Treatment Can Complicate Cataract Surgery
【24h】

Floppy Iris Syndrome: Why BPH Treatment Can Complicate Cataract Surgery

机译:软盘虹膜综合征:为什么BPH治疗会使白内障手术复杂化

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Another unexpected and remarkable finding is that IFIS can occur more than one year after tamsulosin has been discontinued.1,2 Ninety-five percent of ASCRS survey respondents have experienced IFIS in patients with only a previous history of alpha-1 antagonist use.8 Histopathologic analysis of autopsy eyes from patients who were taking tamsulosin shows atrophy of the iris dilator muscle, which would be consistent with a semipermanent drug effect.9 Because stopping alpha blockers pre-operatively is of questionable benefit, only 11 percent of survey respondents routinely discontinue tamsulosin before cataract surgery.8 Ophthalmologists can now anticipate IFIS by eliciting a history of past or current systemic alpha-blocker use, and a number of alternative surgical strategies can be used to improve outcomes for these patients.1,2 However, ophthalmologists remain wary of the surgical complications associated with IFIS, such as iris damage, torn lens capsules, and vitreous prolapse.8 Ninety-five percent of the ASCRS survey respondents believe that tamsulosin still increases the difficulty of cataract surgery, and 77 percent believe that it increases the risks.8 Nearly two thirds of respondents would avoid tamsulosin if they themselves had a mildly symptomatic cataract.8 This group would take a nonselective alpha-1 antagonist, avoid alpha-1 antagonists altogether, or have their mildly symptomatic cataract removed first.
机译:另一个出乎意料且引人注目的发现是,坦索罗辛停用后IFIS可能发生超过一年。1,2在接受ASCRS调查的受访者中,有95%的患者曾有过使用过α-1拮抗剂的病史。8对服用坦索罗辛的患者的尸检眼睛进行的分析显示虹膜扩张肌萎缩,这与半永久性药物作用相符。9由于术前停止使用α受体阻滞剂的益处值得怀疑,因此只有11%的调查受访者例行停用坦索罗辛白内障手术前。8眼科医生现在可以通过回顾过去或当前使用全身性α受体阻滞剂的病史来预测IFIS,并且可以使用多种替代性手术策略来改善这些患者的预后。1,2但是,眼科医生仍需谨慎与IFIS相关的手术并发症,例如虹膜损伤,晶状体囊撕裂和玻璃体脱垂[8]。 ASCRS调查的受访者中有5%认为坦洛新仍会增加白内障手术的难度,而77%的坦索洛辛会增加白内障手术的风险。8如果三分之二的患者自身患有轻度症状性白内障,他们会避免使用坦索罗辛。8服用非选择性的α-1拮抗剂,完全避免使用α-1拮抗剂,或先去除其轻度症状性白内障。

著录项

  • 来源
    《American Family Physician》 |2009年第12期|p.1051-1053|共3页
  • 作者

    David F Chang;

  • 作者单位

    DAVID F. CHANG, MD, University of California, San Francisco, CaliforniaAddress correspondence to David F. Chang, MD, at dceye@earthlink.net. Reprints are not available from the author.Author disclosure: Nothing to disclose.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号